Zyl is hopefully not going down path of it former self Zyotect. Delay are causing this sell down we need to get some certainty otherwise it will keep falling.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025